The OTC Drugs & Dietary Supplements Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Self-Care Driving Market Growth
People in emerging and industrialized countries are now aware of their health, fitness and wellness programs, and this trend is growing worldwide. Immunization and vaccination, precautionary steps to decrease mortality among children and raise children’s immunity, improved living standards in many countries, and nutritional supplements are major efforts that have been adopted globally to extend people’s life expectancy.
Self-care is defined as the treatment of diseases through self-diagnosis without the assistance of a physician. Body aches and pains, fever, cough, colds, allergies, acne and other skincare difficulties, oral and dental hygiene, and gastrointestinal disorders such as indigestion and acidity can all be treated quickly with a self-care approach. The scope of self-care has expanded over time, and it is now not confined to primary care, but also includes improving health and well-being to reduce the risk of disease.
Importance of Dietary Campaigns Anticipated to Fuel Market Growth
Public health agencies, enforcement agencies, associations, industry, and other groups should invest in educational programs which provide advice on picking food supplements of quality and describe potential risks of goods that are not self-assured in their identity or quality. Consumers should be made aware that independent verification procedures from third parties can help establish the representations of products and ingredients. Sensitizing campaigns should focus on the most sensitive or expected physiological impacts of low-quality foodstuffs in consumers’ segments (e.g. senior citizens, pregnant women, military people, etc.)
What Questions Should You Ask before Buying a Market Research Report?
• How is the OTC drugs & dietary supplements market evolving?
• What is driving and restraining the OTC drugs & dietary supplements market?
• How will each OTC drugs & dietary supplements submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each OTC drugs & dietary supplements submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading OTC drugs & dietary supplements markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the OTC drugs & dietary supplements projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of
OTC drugs & dietary supplements projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the OTC drugs & dietary supplements market?
• Where is the OTC drugs & dietary supplements market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the OTC drugs & dietary supplements market today, and over the next 10 years:
• Our 400-page report provides 167 tables and 224 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the OTC drugs & dietary supplements market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Category
• Cough
• Cold and Flu Drugs
• Analgesics
• Dermatological
• Vitamins and Minerals
• Weight Loss/Diet Products
• Gastrointestinal Drugs
• Allergy
• Others
Dosage Form
• Tablets
• Hard Capsules
• Powders
• Ointments
• Soft Capsules
• Liquids
• Others
Product
• Branded Drugs
• Generic Drugs
Distribution Channel
• Pharmacies/Drugstores
• Supermarkets/Hypermarkets
• Convenience Stores
• Online Drugstores
• Health Food Stores
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 34 leading national markets:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Italy
• Spain
• Russia
• Belgium
• Switzerland
• The Netherlands
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Singapore
• Thailand
• Malaysia
• Indonesia
• Philippines
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Colombia
• Argentina
• Rest of Latin America
MEA
• South Africa
• Turkey
• Saudi Arabia
• UAE
• Qatar
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the OTC Drugs & Dietary Supplements Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Abbott
• Alcon
• Alkem Labs
• Bayer AG
• Cipla Inc.
• Dr. Reddy’s Laboratories Ltd.
• F. Hoffmann-La Roche Ltd
• Fresenius Medical Care AG & Co. KGaA
• Glanbia PLC
• H. Lundbeck A/S
• Haleon plc
• Herbalife International of America, Inc.
• Johnson & Johnson Services, Inc.
• Lupin
• Nature’s Sunshine Products, Inc.
• Nippon Chemiphar Co., Ltd.
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Reckitt Benckiser Group PLC
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Taisho Pharmaceutical Holdings Co., Ltd.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
Overall world revenue for OTC Drugs & Dietary Supplements Market, 2022 to 2032 in terms of value the market will surpass US$227.92 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the OTC Drugs & Dietary Supplements Market, 2022 to 2032 report help you?
In summary, our 400-page report provides you with the following knowledge:
• Revenue forecasts to 2032 for OTC Drugs & Dietary Supplements Market, 2022 to 2032 Market, with forecasts for category, dosage form, product, and distribution channel, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for five regional and 34 key national markets – See forecasts for the OTC Drugs & Dietary Supplements Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 26 of the major companies involved in the OTC Drugs & Dietary Supplements Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the OTC Drugs & Dietary Supplements Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today OTC Drugs & Dietary Supplements Market Report 2022-2032: Forecasts by Category (Cough, Cold and Flu Drugs, Analgesics, Dermatological, Vitamins and Minerals, Weight Loss/Diet Products, Gastrointestinal Drugs, Allergy, Others), by Dosage Form (Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, Others), by Product (Branded Drugs, Generic Drugs), by Distribution Channel (Pharmacies/Drugstores, Supermarkets/Hypermarkets, Convenience Stores, Online Drugstores, Health Food Stores, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to OTC Drugs & Dietary Supplements Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Self-Care in the Global Health System
3.2.1.2 Importance of Dietary Campaigns Driving Market Growth
3.2.2 Market Restraining Factors
3.2.2.1 Concentration of Rx Drugs Likely to Hamper Market Growth
3.2.2.2 Manufacturing Issues to Stifle Industry Growth
3.2.3 Market Opportunities
3.2.3.1 Growth Opportunities will Emerge as a Result of Demographic & Economic Changes
3.2.3.2 Emerging Markets Are Booming
3.2.3.3 Shift Towards Plant-based Supplements
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors
3.5.2 Economic Factors
3.5.3 Social Factors
3.5.4 Technological Factors
4 OTC Drugs & Dietary Supplements Industry Structure
4.1 Overview
4.2 Requirements for an OTC Pharmaceutical Drug
4.3 OTC Switching
4.3.1 A Prescription Medicine Switched To OTC
4.3.2 Manufacturing and Distribution of OTC Pharmaceuticals
4.4 Regulation of OTC Pharmaceuticals
4.4.1 U.S.
4.4.2 Japan
4.4.3 Europe
4.4.4 Other Countries
5 OTC Drugs & Dietary Supplements Market Analysis by Category
5.1 Key Findings
5.2 Category Segment Growth Prospects
5.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Category
5.4 Cough, Cold and Flu Drugs
5.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 Analgesics
5.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.5.2 Market Share by Region, 2022 & 2032 (%)
5.6 Dermatological
5.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.6.2 Market Share by Region, 2022 & 2032 (%)
5.7 Vitamins and Minerals
5.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.7.2 Market Share by Region, 2022 & 2032 (%)
5.8 Weight Loss/Diet Products
5.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.8.2 Market Share by Region, 2022 & 2032 (%)
5.9 Gastrointestinal Drugs
5.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.9.2 Market Share by Region, 2022 & 2032 (%)
5.10 Allergy
5.10.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.10.2 Market Share by Region, 2022 & 2032 (%)
5.11 Others
5.11.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.11.2 Market Share by Region, 2022 & 2032 (%)
6 OTC Drugs & Dietary Supplements Market Analysis by Dosage Form
6.1 Key Findings
6.2 Dosage Form Segment Growth Prospects
6.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Dosage Form
6.4 Tablets
6.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.5 Hard Capsules
6.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.5.2 Market Share by Region, 2022 & 2032 (%)
6.6 Powders
6.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.6.2 Market Share by Region, 2022 & 2032 (%)
6.7 Ointments
6.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.7.2 Market Share by Region, 2022 & 2032 (%)
6.8 Soft Capsules
6.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.8.2 Market Share by Region, 2022 & 2032 (%)
6.9 Liquids
6.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.9.2 Market Share by Region, 2022 & 2032 (%)
6.10 Others
6.10.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.10.2 Market Share by Region, 2022 & 2032 (%)
7 OTC Drugs & Dietary Supplements Market Analysis by Product Type
7.1 Key Findings
7.2 Product Type Segment Growth Prospects
7.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Product Type
7.4 Branded Drugs
7.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 Generic Drugs
7.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
7.5.2 Market Share by Region, 2022 & 2032 (%)
8 OTC Drugs & Dietary Supplements Market Analysis by Distribution Channel
8.1 Key Findings
8.2 Distribution Channel Segment Growth Prospects
8.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Distribution Channel
8.4 Pharmacies/Drugstores
8.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.4.2 Market Share by Region, 2022 & 2032 (%)
8.5 Supermarkets/Hypermarkets
8.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.5.2 Market Share by Region, 2022 & 2032 (%)
8.6 Convenience Stores
8.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.6.2 Market Share by Region, 2022 & 2032 (%)
8.7 Online Drugstores
8.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.7.2 Market Share by Region, 2022 & 2032 (%)
8.8 Health Food Stores
8.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.8.2 Market Share by Region, 2022 & 2032 (%)
8.9 Others
8.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.9.2 Market Share by Region, 2022 & 2032 (%)
9 OTC Drugs & Dietary Supplements Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
10 North America OTC Drugs & Dietary Supplements Market Analysis
10.1 Key Findings
10.2 North America OTC Drugs & Dietary Supplements Market Attractiveness Index
10.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
10.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
10.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
10.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
10.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
10.9 U.S.
10.10 Canada
11 Europe OTC Drugs & Dietary Supplements Market Analysis
11.1 Key Findings
11.2 Europe OTC Drugs & Dietary Supplements Market Attractiveness Index
11.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
11.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
11.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
11.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
11.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
11.9 Germany
11.10 UK
11.11 France
11.12 Italy
11.13 Spain
11.14 Russia
11.15 Belgium
11.16 Switzerland
11.17 Netherlands
11.18 Rest of Europe
12 Asia Pacific OTC Drugs & Dietary Supplements Market Analysis
12.1 Key Findings
12.2 Asia Pacific OTC Drugs & Dietary Supplements Market Attractiveness Index
12.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
12.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
12.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
12.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
12.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
12.9 Japan
12.10 China
12.11 India
12.12 South Korea
12.13 Australia
12.14 Singapore
12.15 Thailand
12.16 Malaysia
12.17 Indonesia
12.18 Philippines
12.19 Rest of Asia Pacific
13 Latin America OTC Drugs & Dietary Supplements Market Analysis
13.1 Key Findings
13.2 Latin America OTC Drugs & Dietary Supplements Market Attractiveness Index
13.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
13.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
13.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
13.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
13.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
13.9 Brazil
13.10 Mexico
13.11 Argentina
13.12 Colombia
13.13 Rest of Latin America
14 MEA OTC Drugs & Dietary Supplements Market Analysis
14.1 Key Findings
14.2 MEA OTC Drugs & Dietary Supplements Market Attractiveness Index
14.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
14.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
14.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
14.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
14.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
14.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
14.9 South Africa
14.10 Turkey
14.11 Saudi Arabia
14.12 UAE
14.13 Qatar
14.14 Rest of MEA
15 Company Profiles
15.1 Johnson & Johnson Services, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.3.1 Net Revenue, 2017-2021
15.1.3.2 Gross Profit, 2017-2021
15.1.3.3 R&D, 2017-2021
15.1.4 Product Benchmarking
15.1.5 Strategic Outlook
15.2 Haleon plc
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Product Benchmarking
15.2.4 Strategic Outlook
15.3 Sanofi
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2021
15.3.3.2 Gross Profit, 2017-2021
15.3.3.3 R&D, 2017-2021
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Reckitt Benckiser Group PLC
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2017-2021
15.4.3.2 Gross Profit, 2017-2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 Bayer AG
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2017-2021
15.5.3.2 Gross Profit, 2017-2021
15.5.3.3 R&D, 2017-2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Perrigo Company plc
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2017-2021
15.6.3.2 Gross Profit, 2017-2021
15.6.3.3 R&D, 2017-2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Viatris Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2017-2021
15.7.3.2 Gross Profit, 2017-2021
15.7.3.3 R&D, 2017-2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Takeda Pharmaceutical Company Limited
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2017-2021
15.8.3.2 Gross Profit, 2017-2021
15.8.3.3 R&D, 2017-2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Taisho Pharmaceutical Holdings Co., Ltd.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2017-2021
15.9.3.2 R&D, 2017-2021
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Nippon Chemiphar Co., Ltd.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2017-2021
15.10.3.2 R&D, 2017-2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 H. Lundbeck A/S
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2017-2021
15.11.3.2 R&D, 2017-2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Teva Pharmaceutical Industries Ltd.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2017-2021
15.12.3.2 Gross Profit, 2017-2021
15.12.3.3 R&D, 2017-2021
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Novartis AG
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2017-2021
15.13.3.2 Gross Profit, 2017-2021
15.13.3.3 R&D, 2017-2021
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Pfizer Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue, 2017-2021
15.14.3.2 Gross Profit, 2017-2021
15.14.3.3 R&D, 2017-2021
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Abbott
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2017-2021
15.15.3.2 Gross Profit, 2017-2021
15.15.3.3 R&D, 2017-2021
15.15.4 Product Benchmarking
15.15.5 Strategic Outlook
15.16 Fresenius Medical Care AG & Co. KGaA
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2017-2021
15.16.3.2 Gross Profit, 2017-2021
15.16.3.3 R&D, 2017-2021
15.16.4 Product Benchmarking
15.16.5 Strategic Outlook
15.17 Sun Pharmaceutical Industries Ltd.
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2018-2021
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook
15.18 F. Hoffmann-La Roche Ltd
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2017-2021
15.18.3.2 Gross Profit, 2017-2021
15.18.3.3 R&D, 2017-2021
15.18.4 Product Benchmarking
15.18.5 Strategic Outlook
15.19 Lupin
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Product Benchmarking
15.19.4 Strategic Outlook
15.20 Alcon
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Financial Analysis
15.20.3.1 Net Revenue, 2017-2021
15.20.3.2 Gross Profit, 2017-2021
15.20.3.3 R&D, 2017-2021
15.20.4 Product Benchmarking
15.20.5 Strategic Outlook
15.21 Herbalife International of America, Inc.
15.21.1 Company Snapshot
15.21.2 Company Overview
15.21.3 Product Benchmarking
15.22 Glanbia PLC
15.22.1 Company Snapshot
15.22.2 Company Overview
15.22.3 Financial Analysis
15.22.3.1 Net Revenue, 2017-2021
15.22.3.2 Gross Profit, 2017-2021
15.22.4 Product Benchmarking
15.23 Nature’s Sunshine Products, Inc.
15.23.1 Company Snapshot
15.23.2 Company Overview
15.23.3 Product Benchmarking
15.24 Alkem Labs
15.24.1 Company Snapshot
15.24.2 Company Overview
15.24.3 Financial Analysis
15.24.3.1 Net Revenue, 2017-2021
15.24.4 Product Benchmarking
15.24.5 Strategic Outlook
15.25 Cipla Inc.
15.25.1 Company Snapshot
15.25.2 Company Overview
15.25.3 Financial Analysis
15.25.3.1 Net Revenue, 2017-2021
15.25.4 Product Benchmarking
15.25.5 Strategic Outlook
15.26 Dr. Reddy’s Laboratories Ltd.
15.26.1 Company Snapshot
15.26.2 Company Overview
15.26.3 Financial Analysis
15.26.3.1 Net Revenue, 2017-2021
15.26.3.2 Gross Profit, 2017-2021
15.26.3.3 R&D, 2017-2021
15.26.4 Product Benchmarking
15.26.5 Strategic Outlook
16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players
List of Tables
Table 1 OTC Drugs & Dietary Supplements Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “V” Shaped Recovery
Table 3 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “U” Shaped Recovery
Table 4 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “W” Shaped Recovery
Table 5 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “L” Shaped Recovery
Table 6 OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 7 Cough, Cold and Flu Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 8 Analgesics Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 9 Dermatological Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Vitamins and Minerals Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 11 Weight Loss/Diet Products Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 12 Gastrointestinal Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 13 Allergy Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 16 Tablets Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 17 Hard Capsules Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 18 Powders Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 19 Ointments Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 20 Soft Capsules Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 21 Liquids Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 23 OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 24 Branded Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 25 Generic Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 26 OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 27 Pharmacies/Drugstores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 28 Supermarkets/Hypermarkets Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 29 Convenience Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 30 Online Drug Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Health Food Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 32 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 33 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 34 North America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 35 North America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 North America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 37 North America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 38 North America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 39 U.S. OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 40 Canada OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Europe OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 42 Europe OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 43 Europe OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 44 Europe OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 45 Europe OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 46 Germany OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 47 UK OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 48 France OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 49 Italy OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 50 Spain OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Russia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 52 Belgium OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 53 Switzerland OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 54 Netherlands OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 55 Rest of Europe OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 56 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 57 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 58 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 59 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 60 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 61 Japan OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 62 China OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 63 India OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 64 South Korea OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 65 Australia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 66 Singapore OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 67 Thailand OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 68 Malaysia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 69 Indonesia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 70 Philippines OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Rest of Asia Pacific OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 72 Latin America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 73 Latin America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 74 Latin America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 75 Latin America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 76 Latin America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 Brazil OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 78 Mexico OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 79 Argentina OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 80 Colombia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 81 Rest of Latin America OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 82 MEA OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 83 MEA OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 84 MEA OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 85 MEA OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 86 MEA OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 87 South Africa OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 88 Turkey OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 89 Saudi Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 90 UAE OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 91 Qatar OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 Rest of MEA Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 93 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 95 Johnson & Johnson Services, Inc.: Strategic Outlook
Table 96 Haleon plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Haleon plc: Product Benchmarking
Table 98 Haleon plc: Strategic Outlook
Table 99 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Sanofi: Product Benchmarking
Table 101 Sanofi: Strategic Outlook
Table 102 Reckitt Benckiser Group PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Reckitt Benckiser Group PLC: Product Benchmarking
Table 104 Reckitt Benckiser Group PLC: Strategic Outlook
Table 105 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Bayer AG: Product Benchmarking
Table 107 Bayer AG: Strategic Outlook
Table 108 Perrigo Company plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Perrigo Company plc: Product Benchmarking
Table 110 Perrigo Company plc: Strategic Outlook
Table 111 Viatris Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Viatris Inc.: Product Benchmarking
Table 113 Viatris Inc.: Strategic Outlook
Table 114 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 116 Takeda Pharmaceutical Company Limited: Strategic Outlook
Table 117 Taisho Pharmaceutical Holdings Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Taisho Pharmaceutical Holdings Co., Ltd.: Product Benchmarking
Table 119 Taisho Pharmaceutical Holdings Co., Ltd.: Strategic Outlook
Table 120 Nippon Chemiphar Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Nippon Chemiphar Co., Ltd.: Product Benchmarking
Table 122 Nippon Chemiphar Co., Ltd.: Strategic Outlook
Table 123 H. Lundbeck A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 H. Lundbeck A/S: Product Benchmarking
Table 125 H. Lundbeck A/S: Strategic Outlook
Table 126 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 128 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 129 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Novartis AG: Product Benchmarking
Table 131 Novartis AG: Strategic Outlook
Table 132 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Pfizer Inc.: Product Benchmarking
Table 134 Pfizer Inc.: Strategic Outlook
Table 135 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Abbott: Product Benchmarking
Table 137 Abbott: Strategic Outlook
Table 138 Fresenius Medical Care AG & Co. KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Fresenius Medical Care AG & Co. KGaA: Product Benchmarking
Table 140 Fresenius Medical Care AG & Co. KGaA: Strategic Outlook
Table 141 Sun Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 Sun Pharmaceutical Industries Ltd.: Product Benchmarking
Table 143 Sun Pharmaceutical Industries Ltd.: Strategic Outlook
Table 144 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 146 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 147 Lupin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 Lupin: Product Benchmarking
Table 149 Lupin: Strategic Outlook
Table 150 Alcon: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 Alcon: Product Benchmarking
Table 152 Alcon: Strategic Outlook
Table 153 Herbalife International of America, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 154 Herbalife International of America, Inc.: Product Benchmarking
Table 155 Glanbia PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Glanbia PLC: Product Benchmarking
Table 157 Nature’s Sunshine Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 Nature’s Sunshine Products, Inc.: Product Benchmarking
Table 159 Alkem Labs: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 160 Alkem Labs: Product Benchmarking
Table 161 Alkem Labs: Strategic Outlook
Table 162 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 Cipla Inc.: Product Benchmarking
Table 164 Cipla Inc.: Strategic Outlook
Table 165 Dr. Reddy’s Laboratories Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Dr. Reddy’s Laboratories Ltd.: Product Benchmarking
Table 167 Dr. Reddy’s Laboratories Ltd.: Strategic Outlook
List of Figures
Figure 1 OTC Drugs & Dietary Supplements Market Segmentation
Figure 2 OTC Drugs & Dietary Supplements Market by Category: Market Attractiveness Index
Figure 3 OTC Drugs & Dietary Supplements Market by Dosage Form: Market Attractiveness Index
Figure 4 OTC Drugs & Dietary Supplements Market by Product Type: Market Attractiveness Index
Figure 5 OTC Drugs & Dietary Supplements Market by Distribution Channel: Market Attractiveness Index
Figure 6 OTC Drugs & Dietary Supplements Market Attractiveness Index by Region
Figure 7 OTC Drugs & Dietary Supplements Market: Market Dynamics
Figure 8 COVID Impact Analysis: OTC Drugs & Dietary Supplements Market Recovery Scenarios
Figure 9 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “V” Shaped Recovery
Figure 10 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “U” Shaped Recovery
Figure 11 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “W” Shaped Recovery
Figure 12 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “L” Shaped Recovery
Figure 13 OTC Drugs & Dietary Supplements Market: Porter’s Five Forces Analysis
Figure 14 OTC Pharmaceutical Supply Chain
Figure 15 OTC Drugs & Dietary Supplements Market Attractiveness Index by Category
Figure 16 OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 17 OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022, 2027, 2032 (%)
Figure 18 Cough, Cold and Flu Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 19 Cough, Cold and Flu Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Analgesics Market Forecast by Region, 2022-2032 (US$ billion)
Figure 21 Analgesics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 22 Dermatological Market Forecast by Region, 2022-2032 (US$ billion)
Figure 23 Dermatological Market Share Forecast by Region, 2022 & 2032 (%)
Figure 24 Vitamins and Minerals Market Forecast by Region, 2022-2032 (US$ billion)
Figure 25 Vitamins and Minerals Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Weight Loss/Diet Products Market Forecast by Region, 2022-2032 (US$ billion)
Figure 27 Weight Loss/Diet Products Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Gastrointestinal Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 29 Gastrointestinal Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 30 Allergy Market Forecast by Region, 2022-2032 (US$ billion)
Figure 31 Allergy Market Share Forecast by Region, 2022 & 2032 (%)
Figure 32 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 33 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 34 OTC Drugs & Dietary Supplements Market Attractiveness Index by Category
Figure 35 OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 36 OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022, 2027, 2032 (%)
Figure 37 Tablets Market Forecast by Region, 2022-2032 (US$ billion)
Figure 38 Tablets Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Hard Capsules Market Forecast by Region, 2022-2032 (US$ billion)
Figure 40 Hard Capsules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Powders Market Forecast by Region, 2022-2032 (US$ billion)
Figure 42 Powders Market Share Forecast by Region, 2022 & 2032 (%)
Figure 43 Ointments Market Forecast by Region, 2022-2032 (US$ billion)
Figure 44 Ointments Market Share Forecast by Region, 2022 & 2032 (%)
Figure 45 Soft Capsules Market Forecast by Region, 2022-2032 (US$ billion)
Figure 46 Soft Capsules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 47 Liquids Market Forecast by Region, 2022-2032 (US$ billion)
Figure 48 Liquids Market Share Forecast by Region, 2022 & 2032 (%)
Figure 49 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 50 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 51 OTC Drugs & Dietary Supplements Market Attractiveness Index by Product Type
Figure 52 OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 53 OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022, 2027, 2032 (%)
Figure 54 Branded Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 55 Branded Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 56 Generic Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 57 Generic Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 58 OTC Drugs & Dietary Supplements Market Attractiveness Index by Distribution Channel
Figure 59 OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 60 OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022, 2027, 2032 (%)
Figure 61 Pharmacies/Drugstores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 62 Pharmacies/Drugstores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 63 Supermarkets/Hypermarkets Market Forecast by Region, 2022-2032 (US$ billion)
Figure 64 Supermarkets/Hypermarkets Market Share Forecast by Region, 2022 & 2032 (%)
Figure 65 Convenience Stores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 66 Convenience Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 67 Online Drugstores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 68 Online Drugstores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 69 Health Food Stores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 70 Health Food Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 71 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 72 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 73 OTC Drugs & Dietary Supplements Market Forecast by Region 2022 & 2032 (Revenue, CAGR%)
Figure 74 OTC Drugs & Dietary Supplements Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 75 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn)
Figure 76 North America OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 77 North America OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 78 North America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 79 North America OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 80 North America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 81 North America OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 82 North America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 83 North America OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 84 North America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 85 North America OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 86 North America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 87 North America OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 88 U.S. OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 89 Canada OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 90 Europe OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 91 Europe OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 92 Europe OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 93 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 94 Europe OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 95 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 96 Europe OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 97 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 98 Europe OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 99 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 100 Europe OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 101 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 102 Germany OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 103 UK OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 104 France OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 105 Italy OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 106 Spain OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 107 Russia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 108 Belgium OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 109 Switzerland OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 110 Netherlands OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 111 Rest of Europe OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 112 Asia Pacific OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 113 Asia Pacific OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 114 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 115 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 116 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 117 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 118 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 119 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 120 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 121 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 122 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 123 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 124 Japan OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 125 China OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 126 India OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 127 South Korea OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 128 Australia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 129 Singapore OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 130 Thailand OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 131 Malaysia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 132 Indonesia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 133 Philippines OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 134 Rest of Asia Pacific OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 135 Latin America OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 136 Latin America OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 137 Latin America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 138 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 139 Latin America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 140 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 141 Latin America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 142 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 143 Latin America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 144 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 145 Latin America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 146 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 147 Brazil OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 148 Mexico OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 149 Argentina OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 150 Colombia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 151 Rest of Latin America OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 152 MEA OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 153 MEA OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 154 MEA OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 155 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 156 MEA OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 157 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 158 MEA OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 159 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 160 MEA OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 161 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 162 MEA OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 163 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 164 South Africa OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 165 Turkey OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 166 Saudi Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 167 UAE OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 168 Qatar OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 169 Rest of MEA OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 170 Johnson & Johnson Services, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 171 Johnson & Johnson Services, Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 172 Johnson & Johnson Services, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 173 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 174 Sanofi: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 175 Sanofi: R&D, 2017-2021 (US$ million, AGR%)
Figure 176 Reckitt Benckiser Group PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 177 Reckitt Benckiser Group PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 178 Bayer AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 179 Bayer AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 180 Bayer AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 181 Perrigo Company plc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 182 Perrigo Company plc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 183 Perrigo Company plc: R&D, 2017-2021 (US$ million, AGR%)
Figure 184 Viatris Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 185 Viatris Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 186 Viatris Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 187 Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Takeda Pharmaceutical Company Limited: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 189 Takeda Pharmaceutical Company Limited: R&D, 2017-2021 (US$ million, AGR%)
Figure 190 Taisho Pharmaceutical Holdings Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 191 Taisho Pharmaceutical Holdings Co., Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 192 Nippon Chemiphar Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 193 Nippon Chemiphar Co., Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 194 H. Lundbeck A/S: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 195 H. Lundbeck A/S: R&D, 2017-2021 (US$ million, AGR%)
Figure 196 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 197 Teva Pharmaceutical Industries Ltd.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 198 Teva Pharmaceutical Industries Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 199 Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 200 Novartis AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 201 Novartis AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 202 Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 203 Pfizer Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 204 Pfizer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 205 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 206 Abbott: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 207 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 208 Fresenius Medical Care AG & Co. KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 209 Fresenius Medical Care AG & Co. KGaA: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 210 Fresenius Medical Care AG & Co. KGaA: R&D, 2017-2021 (US$ million, AGR%)
Figure 211 Sun Pharmaceutical Industries Ltd.: Net Revenue, 2018-2021 (US$ million, AGR%)
Figure 212 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 213 F. Hoffmann-La Roche Ltd: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 214 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%)
Figure 215 Alcon: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 216 Alcon: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 217 Alcon: R&D, 2017-2021 (US$ million, AGR%)
Figure 218 Glanbia PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 219 Glanbia PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 220 Alkem Labs: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 221 Cipla Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 222 Dr. Reddy’s Laboratories Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 223 Dr. Reddy’s Laboratories Ltd.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 224 Dr. Reddy’s Laboratories Ltd.: R&D, 2017-2021 (US$ million, AGR%)
List of Companies Profiled in the Report
Abbott
Alcon
Alkem Labs
Bayer AG
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
F. Hoffmann-La Roche Ltd
Fresenius Medical Care AG & Co. KGaA
Glanbia PLC
H. Lundbeck A/S
Haleon plc
Herbalife International of America, Inc.
Johnson & Johnson Services, Inc.
Lupin
Nature’s Sunshine Products, Inc.
Nippon Chemiphar Co., Ltd.
Novartis AG
Perrigo Company plc
Pfizer Inc.
Reckitt Benckiser Group PLC
Sanofi
Sun Pharmaceutical Industries Ltd.
Taisho Pharmaceutical Holdings Co., Ltd.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
List of Other Companies Mentioned in the Report
23andMe
Abbott Medical Optics
Achelios Therapeutics, Inc.
Acrux
Agrifen
AiPing Pharmaceutical
Akron Pharmaceuticals
Allegiant Health
Alliance Boots
Alvogen Pharmaceuticals Company
Amol Pharmaceuticals Private Limited
Apotex
Arena Pharmaceuticals
Aspen Australia
Aspen Global Inc.
Aspirina
AstraZeneca PLC
Bal Pharma ltd.
Bayer
Beximco Pharmaceuticals
Biocartis Group NV
Biocon Ltd.
Boehringer Ingelheim
Bristol-Myres Squibb
Cardinal Health
CR Pharmaceutical
Daiichi Sankyo
Eisai Co., Ltd.
Eli Lilly
Guangzhou Pharmaceutical Company, Ltd.
iNova Pharmaceuticals
Lipa Pharmaceuticals
Marksans Pharma
Mayne Pharma
McKesson Corporation
Momenta Pharmaceuticals, Inc.
Nektar Therapeutics
NeoStrata Company, Inc.
Nihon Eisai Co., Ltd.
Phoenix
Procter & Gamble
Shanghai Pharmaceuticals
Sinopharm
TSI Pharmaceuticals
Valenta Pharm
Vifor Pharma
Vista Pharmaceuticals
List of Associations Mentioned in the Report
African Pharmaceutical Distribution Association
All Indian Origin Chemists & Distributors Ltd ( AIOCD Ltd)
Association for Accessible Medicines (AAM)
Association of the British Pharmaceutical Industry (ABPI)
British Association of European Pharmaceutical Distributors (BAEPD)
Canadian Association for Pharmacy Distribution Management (CAPDM)
Canadian Generic Pharmaceutical Association (CGPA)
Drug Information Association (DIA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Healthcare Distribution Association
Healthcare Distribution Alliance (HDA)
Healthcare Distribution Management Association
Indian Pharmaceutical Association
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
International Society for Pharmaceutical Engineering (ISPE):
IPEC Europe
Kenya Pharmaceutical Distribution Association
National Pharmaceutical Services Association (NPSA)
Pharmaceutical Association of Malaysia (PhAMA)
Pharmaceutical Research and Manufacturers of America (PhRMA)
Singapore Association of Pharmaceutical Industries (SAPI)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
